With many lives on the line waiting for an effective treatment for the ravages of the CCP Virus (coronavirus) that has decimated most countries across the globe, President Trump has cut through red tape and granted an emergency authorization to enable medical staff to treat CCP Virus patients with convalescent plasma.

The president addressed reporters at the White House on Sunday, Aug. 23, and informed them he had issued an emergency authorization to allow for the treatment, which involves taking plasma from recovering patients of the virus, and giving it to others fighting off the virus, as it has been found to be rich in antibodies to help them overcome the infection.

“This is a powerful therapy that transfuses very very strong antibodies from the blood of recovered patients to help treat patients battling a current infection,” President Trump said, adding that the authorization will “expand access to this treatment.”

The evidence so far obtained is inconclusive as to how it actually works.

“Based on the science and the data, the FDA has made the independent determination that the treatment is safe and very effective,” the president said, as he urged all recovered CCP Virus patients in the USA to donate their blood plasma, reports Fox News.

White House press secretary Kayleigh McEnany had tweeted the previous night that the president’s press conference on Sunday involved “a major therapeutic breakthrough on the China virus.”

Last week, White House officials complained that delays by the FDA to approve vaccines and therapeutics to treat patients suffering from the virus were politically motivated.

The White House had become impatient with the holdup of plasma approval to be used as a treatment, and White House chief of staff Mark Meadows said, “We’ve looked at a number of people that are not being as diligent as they should be in terms of getting to the bottom of it.”

“This president is about cutting red tape,” said Meadows in an interview on ABC’s “This Week.” “He had to make sure that they felt the heat. If they don’t see the light, they need to feel the heat because the American people are suffering.”

The president had criticized the system that was holding up treatment for the virus, which to date had taken the lives of more than 176,000 Americans. “The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” President Trump tweeted. “Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”

Convalescent plasma has been used as a treatment in the past to give immunity against the flu and measles, before vaccinations were invented, with history indicating it does work against some diseases but is not effective against others.

The FDA, in announcing the emergency authorization for convalescent plasma stated its benefits, “outweigh the known and potential risks of the product and that there are no adequate, approved, and available alternative treatments,” reported Fox News.

Former FDA Commissioner Scott Gottlieb on CBS’s “Face the Nation” admitted the convalescent plasma treatment was “probably beneficial,” but rejected the president’s claim of a slowdown to delay treatment for political gain.

“I firmly reject the idea they would slow-walk anything or accelerate anything based on any political consideration or any consideration other than what is best for the public health and a real sense of mission to patients,” Gottlieb said.